2159 — Mediwelcome Healthcare Management & Technology Cashflow Statement
0.000.00%
Last trade - 00:00- HK$462.00m
- HK$403.59m
- CNY468.02m
Annual cashflow statement for Mediwelcome Healthcare Management & Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 5.59 | -91 | -96.4 | -45.2 | 6.98 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 6.29 | 12.7 | 22.5 | 20 | -5.58 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -31.1 | 39.2 | -22.2 | 0.73 | -2.39 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.262 | -18.5 | -75.6 | -14.1 | 3.87 |
| Capital Expenditures | -25 | -4.3 | -1.6 | -13.1 | -0.421 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 8.22 | -4.06 | 18.1 | 12.7 | -13 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -16.8 | -8.36 | 16.5 | -0.326 | -13.4 |
| Financing Cash Flow Items | -1.26 | -1.25 | -1.3 | -1.09 | -1.44 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 92.8 | 0.054 | 0.906 | 5.68 | 37.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 76.3 | -26.8 | -58.2 | -8.7 | 27.7 |